Heterologous replacement of the supposed host determining region of avihepadnaviruses: High in vivo infectivity despite low infectivity for hepatocytes

PLoS Pathogens

Volumn 4, Issue 12, 2008, Pages

  Dallmeier, Kai ^a   Schultz, Ursula ^b   Nassal, Michael ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b Cellgenix GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROLIPOAMIDE DEHYDROGENASE; VACCINE; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN; PRE S PROTEIN, DUCK HEPATITIS B VIRUS; PRE-S PROTEIN, DUCK HEPATITIS B VIRUS;

AMINO ACID SEQUENCE; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBIOTIC RESISTANCE; ARTICLE; CHIMERA; CHIMPANZEE; CONTROLLED STUDY; DNA VIRUS; DUCK; FEMALE; FOWL; HEPATITIS B; HEPATITIS B VIRUS; LIVER CELL; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; RISK ASSESSMENT; VERTICAL TRANSMISSION; VIRUS ENVELOPE; VIRUS GENOME; VIRUS INFECTIVITY; VIRUS TRANSMISSION; WILD TYPE; ANIMAL; ANIMAL HEPATITIS; AVIHEPADNAVIRUS; CELL CULTURE; DISEASE TRANSMISSION; DUCKS AND GEESE; GENETIC RECOMBINATION; GENETICS; PATHOGENICITY; PHYSIOLOGY; VIRION; VIROLOGY; VIRUS INFECTION;

ANAS; ANIMALIA; AVES; DNA VIRUSES; DUCK HEPATITIS B VIRUS; HEPATITIS B VIRUS; HERON HEPATITIS B VIRUS; MAMMALIA; PAN;

ANIMALS; ANSERIFORMES; AVIHEPADNAVIRUS; CELLS, CULTURED; CHIMERA; DUCKS; HEPADNAVIRIDAE INFECTIONS; HEPATITIS B VIRUS, DUCK; HEPATITIS, VIRAL, ANIMAL; HEPATOCYTES; RECOMBINATION, GENETIC; VIRAL ENVELOPE PROTEINS; VIRION;

EID: 58149229678     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1000230     Document Type: Article

References (71)

1. Summers J, Mason WS (1982) Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate. Cell 29: 403-415.
2. Seeger C, Mason WS (2000) Hepatitis B virus biology. Microbiol Mol Biol Rev 64: 51-68.
3. Beck J, Nassal M (2007) Hepatitis B virus replication. World J Gastroenterol 13: 48-64.
4. Glebe D, Urban S (2007) Viral and cellular determinants involved in hepadnaviral entry. World J Gastroenterol 13: 22-38.
5. Dallmeier K, Nassal M (2008) Hepadnaviruses have a narrow host range - do they? In: Weber O, Protzer U, eds. Comparative Hepatitis. Basel, Boston: Birkhäuser. pp 303-339.
6. Nassal M (2008) Hepatitis B viruses: reverse transcription a different way. Virus Res 134: 235-249.
7. Bruss V (2007) Hepatitis B virus morphogenesis. World J Gastroenterol 13: 65-73.
8. Tang H, McLachlan A (2002) Avian and mammalian hepadnaviruses have distinct transcription factor requirements for viral replication. J Virol 76: 7468-7472.
9. Hirsch R, Colgrove R, Ganem D (1988) Replication of duck hepatitis B virus in two differentiated human hepatoma cell lines after transfection with cloned viral DNA. Virology 167: 136-142.
10. Glebe D, Aliakbari M, Krass P, Knoop EV, Valerius KP, et al. (2003) Pre-s1 antigen-dependent infection of Tupaia hepatocyte cultures with human hepatitis B virus. J Virol 77: 9511-9521.
11. Köck J, Nassal M, MacNelly S, Baumert TF, Blum HE, et al. (2001) Efficient infection of primary tupaia hepatocytes with purified human and woolly monkey hepatitis B virus. J Virol 75: 5084-5089.
12. Menne S, Cote PJ (2007) The woodchuck as an animal model for pathogenesis and therapy of chronic hepatitis B virus infection. World J Gastroenterol 13: 104-124.
13. Schultz U, Grgacic E, Nassal M (2004) Duck hepatitis B virus: an invaluable model system for HBV infection. Adv Virus Res 63: 1-70.
14. Will H, Cattaneo R, Darai G, Deinhardt F, Schellekens H, et al. (1985) Infectious hepatitis B virus from cloned DNA of known nucleotide sequence. Proc Natl Acad Sci U S A 82: 891-895.
15. Michaels MG, Lanford R, Demetris AJ, Chavez D, Brasky K, et al. (1996) Lack of susceptibility of baboons to infection with hepatitis B virus. Transplantation 61: 350-351.
16. Baptista M, Kramvis A, Jammeh S, Naicker J, Galpin JS, et al. (2003) Follow up of infection of chacma baboons with inoculum containing A and non-A genotypes of hepatitis B virus. World J Gastroenterol 9: 731-735.
17. Seeger C, Marion PL, Ganem D, Varmus HE (1987) In vitro recombinants of ground squirrel and woodchuck hepatitis viral DNAs produce infectious virus in squirrels. J Virol 61: 3241-3247.
18. Marion PL, Cullen JM, Azcarraga RR, Van Davelaar MJ, Robinson WS (1987) Experimental transmission of duck hepatitis B virus to Pekin ducks and to domestic geese. Hepatology 7: 724-731.
19. Seeger C, Baldwin B, Hornbuckle WE, Yeager AE, Tennant BC, et al. (1991) Woodchuck hepatitis virus is a more efficient oncogenic agent than ground squirrel hepatitis virus in a common host. J Virol 65: 1673-1679.
20. Trueba D, Phelan M, Nelson J, Beck F, Pecha BS, et al. (1985) Transmission of ground squirrel hepatitis virus to homologous and heterologous hosts. Hepatology 5: 435-439.
21. Lanford RE, Chavez D, Brasky KM, Burns RB 3rd, Rico-Hesse R (1998) Isolation of a hepadnavirus from the woolly monkey, a New World primate. Proc Natl Acad Sci USA 95: 5757-5761.
22. Prassolov A, Hohenberg H, Kalinina T, Schneider C, Cova L, et al. (2003) New hepatitis B virus of cranes that has an unexpected broad host range. J Virol 77: 1964-1976.
23. Ishikawa T, Ganem D (1995) The pre-S domain of the large viral envelope protein determines host range in avian hepatitis B viruses. Proc Natl Acad Sci U S A 92: 6259-6263.
24. Sprengel R, Kaleta EF, Will H (1988) Isolation and characterization of a hepatitis B virus endemic in herons. J Virol 62: 3832-3839.
25. Kuroki K, Eng F, Ishikawa T, Turck C, Harada F, et al. (1995) gp180, a host cell glycoprotein that binds duck hepatitis B virus particles, is encoded by a member of the carboxypeptidase gene family. J Biol Chem 270: 15022-15028.
26. Li J, Tong S, Lee HB, Perdigoto AL, Spangenberg HC, et al. (2004) Glycine decarboxylase mediates a postbinding step in duck hepatitis B virus infection. J Virol 78: 1873-1881.
27. Glebe D, Urban S, Knoop EV, Cag N, Krass P, et al. (2005) Mapping of the hepatitis B virus attachment site by use of infection-inhibiting preS1 lipopeptides and tupaia hepatocytes. Gastroenterology 129: 234-245.
28. Rollier C, Sunyach C, Barraud L, Madani N, Jamard C, et al. (1999) Protective and therapeutic effect of DNA-based immunization against hepadnavirus large envelope protein. Gastroenterology 116: 658-665.
29. Yuasa S, Cheung RC, Pham Q, Robinson WS, Marion PL (1991) Peptide mapping of neutralizing and nonneutralizing epitopes of duck hepatitis B virus pre-S polypeptide. Virology 181: 14-21.
30. Rollier C, Charollois C, Jamard C, Trepo C, Cova L (2000) Maternally transferred antibodies from DNA-immunized avians protect offspring against hepadnavirus infection. J Virol 74: 4908-4911.
31. Zhang YY, Summers J (2004) Rapid production of neutralizing antibody leads to transient hepadnavirus infection. J Virol 78: 1195-1201.
32. Blanchet M, Sureau C (2007) Infectivity determinants of the hepatitis B virus pre-S domain are confined to the N-terminal 75 amino acid residues. J Virol 81: 5841-5849.
33. Lenhoff RJ, Summers J (1994) Coordinate regulation of replication and virus assembly by the large envelope protein of an avian hepadnavirus. J Virol 68: 4565-4571.
34. Urban S, Gripon P (2002) Inhibition of duck hepatitis B virus infection by a myristoylated pre-S peptide of the large viral surface protein. J Virol 76: 1986-1990.
35. Ganem D, Schneider R (2001) Hepadnaviridae: The Viruses and Their Replication. In: Knipe DM, Howley PM, eds. Fields Virology. 4th ed. Philadelphia: Lippincott Williams & Wilkins. pp 2923-2969.
36. Chouteau P, Le Seyec J, Cannie I, Nassal M, Guguen-Guillouzo C, et al. (2001) A short N-proximal region in the large envelope protein harbors a determinant that contributes to the species specificity of human hepatitis B virus. J Virol 75: 11565-11572.
37. Barrera A, Guerra B, Lee H, Lanford RE (2004) Analysis of host range phenotypes of primate hepadnaviruses by in vitro infections of hepatitis D virus pseudotypes. J Virol 78: 5233-5243.
38. Gudima S, He Y, Chai N, Bruss V, Urban S, et al. (2008) Primary human hepatocytes are susceptible to infection by hepatitis delta virus assembled with envelope proteins of woodchuck hepatitis virus. J Virol 82: 7276-7283.
39. Sureau C (2006) The role of the HBV envelope proteins in the HDV replication cycle. Curr Top Microbiol Immunol 307: 113-131.
40. Jilbert AR, Miller DS, Scougall CA, Turnbull H, Burrell CJ (1996) Kinetics of duck hepatitis B virus infection following low dose virus inoculation: one virus DNA genome is infectious in neonatal ducks. Virology 226: 338-345.
41. Liu N, Tian R, Loeb DD (2003) Base pairing among three cis-acting sequences contributes to template switching during hepadnavirus reverse transcription. Proc Natl Acad Sci USA 100: 1984-1989.
42. Zhang YY, Zhang BH, Theele D, Litwin S, Toll E, et al. (2003) Single-cell analysis of covalently closed circular DNA copy numbers in a hepadnavirus-infected liver. Proc Natl Acad Sci USA 100: 12372-12377.
43. Lenhoff RJ, Luscombe CA, Summers J (1999) Acute liver injury following infection with a cytopathic strain of duck hepatitis B virus. Hepatology 29: 563-571.
44. Cova L, Zoulim F (2004) Duck hepatitis B virus model in the study of hepatitis B virus. Methods Mol Med 96: 261-268.
45. Hsia CC, Purcell RH, Farshid M, Lachenbruch PA, Yu MY (2006) Quantification of hepatitis B virus genomes and infectivity in human serum samples. Transfusion 46: 1829-1835.
46. Anellis A, Werkowski S (1968) Estimation of radiation resistance values of microorganisms in food products. Appl Microbiol 16: 1300-1308.
47. Reed LJ, Muench H (1938) A simple method to determine fifty per cent endpoints. Am J Epidemiol 27: 493-497.
48. Jilbert AR, Wu TT, England JM, Hall PM, Carp NZ, et al. (1992) Rapid resolution of duck hepatitis B virus infections occurs after massive hepatocellular involvement. J Virol 66: 1377-1388.
49. Jilbert AR, Botten JA, Miller DS, Bertram EM, Hall PM, et al. (1998) Characterization of age- and dose-related outcomes of duck hepatitis B virus infection. Virology 244: 273-282.
50. Urban S, Schwarz C, Marx UC, Zentgraf H, Schaller H, et al. (2000) Receptor recognition by a hepatitis B virus reveals a novel mode of high affinity virus-receptor interaction. Embo J 19: 1217-1227.
51. Barrera A, Lanford RE (2004) Infection of primary chimpanzee hepatocytes with recombinant hepatitis D virus particles: a surrogate model for hepatitis B virus. Methods Mol Med 96: 131-142.
52. Lanford RE, Chavez D, Barrera A, Brasky KM (2003) An infectious clone of woolly monkey hepatitis B virus. J Virol 77: 7814-7819.
53. Lenhoff RJ, Luscombe CA, Summers J (1998) Competition in vivo between a cytopathic variant and a wild-type duck hepatitis B virus. Virology 251: 85-95.
54. Goff SP (2004) Retrovirus restriction factors. Mol Cell 16: 849-859.
55. Goff SP (2007) Host factors exploited by retroviruses. Nat Rev Microbiol 5: 253-263.
56. Breiner KM, Schaller H, Knolle PA (2001) Endothelial cell-mediated uptake of a hepatitis B virus: a new concept of liver targeting of hepatotropic microorganisms. Hepatology 34: 803-808.
57. Sherer NM, Lehmann MJ, Jimenez-Soto LF, Horensavitz C, Pypaert M, et al. (2007) Retroviruses can establish filopodial bridges for efficient cell-to-cell transmission. Nat Cell Biol 9: 310-315.
58. Sowinski S, Jolly C, Berninghausen O, Purbhoo MA, Chauveau A, et al. (2008) Membrane nanotubes physically connect T cells over long distances presenting a novel route for HIV-1 transmission. Nat Cell Biol 10: 211-219.
59. Guo H, Mason WS, Aldrich CE, Saputelli JR, Miller DS, et al. (2005) Identification and characterization of avihepadnaviruses isolated from exotic anseriformes maintained in captivity. J Virol 79: 2729-2742.
60. Sheldon J, Ramos B, Garcia-Samaniego J, Rios P, Bartholomeusz A, et al. (2007) Selection of Hepatitis B Virus (HBV) Vaccine Escape Mutants in HBV-Infected and HBV/HIV-Coinfected Patients Failing Antiretroviral Drugs With Anti-HBV Activity. J Acquir Immune Defic Syndr Publish Ahead of Print.
61. Warner N, Locarnini S, Kuiper M, Bartholomeusz A, Ayres A, et al. (2007) The L80I substitution in the reverse transcriptase domain of the hepatitis B virus polymerase is associated with lamivudine resistance and enhanced viral replication in vitro. Antimicrob Agents Chemother 51: 2285-2292.
62. Gripon P, Diot C, Guguen-Guillouzo C (1993) Reproducible high level infection of cultured adult human hepatocytes by hepatitis B virus: effect of polyethylene glycol on adsorption and penetration. Virology 192: 534-540.
63. Gripon P, Rumin S, Urban S, Le Seyec J, Glaise D, et al. (2002) Infection of a human hepatoma cell line by hepatitis B virus. Proc Natl Acad Sci U S A 99: 15655-15660.
64. Krikorian R, Lozach-Perlant A, Ferrier-Rembert A, Hoerner P, Sonntag P, et al. (2007) Standardization of needlestick injury and evaluation of a novel virus-inhibiting protective glove. J Hosp Infect 66: 339-345.
65. Protzer U, Nassal M, Chiang PW, Kirschfink M, Schaller H (1999) Interferon gene transfer by a hepatitis B virus vector efficiently suppresses wild-type virus infection. Proc Natl Acad Sci USA 96: 10818-10823.
66. Summers J, Smith PM, Horwich AL (1990) Hepadnavirus envelope proteins regulate covalently closed circular DNA amplification. J Virol 64: 2819-2824.
67. Hu K, Beck J, Nassal M (2004) SELEX-derived aptamers of the duck hepatitis B virus RNA encapsidation signal distinguish critical and non-critical residues for productive initiation of reverse transcription. Nucleic Acids Res 32: 4377-4389.
68. Xu Z, Ou JH (2004) Endogenous polymerase assay for the analysis of hepatitis B virus in transgenic mice. Methods Mol Med 95: 295-302.
69. Tuttleman JS, Pugh JC, Summers JW (1986) In vitro experimental infection of primary duck hepatocyte cultures with duck hepatitis B virus. J Virol 58: 17-25.
70. Mandart E, Kay A, Galibert F (1984) Nucleotide sequence of a cloned duck hepatitis B virus genome: comparison with woodchuck and human hepatitis B virus sequences. J Virol 49: 782-792.
71. Vorreiter J, Leifer I, Rösler C, Jackevica L, Pumpens P, et al. (2007) Monoclonal antibodies providing topological information on the DHBV core protein and avihepadnaviral nucleocapsid structure. J Virol 81: 13230-13234.